Observational studyFrontiers in endocrinology2026
Obstructive sleep apnea risk and its association with diabetic foot ulcer in patients with type 2 diabetes.
Observational study in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The impact of obstructive sleep apnea on skin wound healing - from preclinical perspective to clinical evidence: A narrative review.Sleep & breathing = Schlaf & Atmung · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obstructive sleep apnea (OSA) is common in type 2 diabetes (T2D) and may contribute to its chronic complications. Whether STOP-Bang-defined OSA risk is associated with diabetic foot ulcer (DFU) severity and outcome remains unclear. We compared STOP-Bang score between T2D patients with and without DFU and explored the association between OSA risk and DFU severity and healing. Methods: We conducted an observational study with a cross-sectional matched case-control comparison including 73 T2D patients with DFU and 73 T2D controls without DFU, matched by age, HbA1c, BMI and smoking. At the study visit, STOP-Bang-defined OSA risk was assessed as a continuous score and categorized as low versus moderate/high risk. In the DFU group, ulcer severity was graded at the same visit with the WIfI classification, and time to healing and amputation was recorded during clinical follow-up. Multivariable logistic regression identified predictors of moderate-to-high amputation risk. Results: In unadjusted analyses, DFU patients had higher STOP-Bang score than controls (4.3 ± 2.0 vs. 3.2 ± 2.2, p=0.004) and more often intermediate/high OSA risk (83.6% vs. 60.3%, p=0.002), although these differences were attenuated after accounting for sex imbalance. Among DFU patients, higher ulcer severity was associated with moderate/high STOP-Bang-defined OSA risk (97.1 vs. 71.8%; p=0.004). Median healing time was longer in those with moderate/high versus low STOP-Bang-defined OSA risk (120.0 vs. 65.0 days, p=0.032). In multivariable analysis, WIfI ulcer severity was associated with male sex, higher STOP-Bang category and poorer metabolic control. Conclusion: STOP-Bang-defined OSA risk was associated with greater DFU severity and delayed wound healing. Incorporating OSA risk stratification into routine assessment of patients with DFU may help identify individuals at higher risk of poor outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.